Description 
At AOFAS Annual Meeting 2023 in Louisville, Kentucky, co-hosts Nicholas Strasser, MD, and J. Benjamin Jackson MD, MBA, discuss with Jaeyoung Kim, MD, the Roger A. Mann Finalist paper “Cervical Ligament Insufficiency in Progressive Collapsing Foot Deformity: It May Be More Important Than We Know.”

Summary
Subluxation at the subtalar joint is one of the major radiographic features that characterize progressive collapsing foot deformity (PCFD). Although it is recognized that the cervical ligament plays an important function in maintaining the subtalar joint's stability, its role and involvement in PCFD is largely unknown. The purpose of this study was to assess the prevalence of cervical ligament insufficiency in patients with PCFD and to establish if the degree of its pathology changes with increasing axial plane deformity. [Source].

Commercial Support
2024 CME Podcasts are provided free to AOFAS members and orthopaedic residents/fellows with funding from the Orthopaedic Foot & Ankle Foundation.

• Recognize the link between cervical ligament insufficiency and progressive collapsing foot deformity (PCFD).
• Identify the prevalence of cervical ligament insufficiency in PCFD and its association with increasing axial plane deformity.
• Determine the impact of axial plane deformity on cervical ligament pathology in PCFD. 

Statement of Need

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.

Accreditation

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

Disclaimer

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.

Disclosure of Conflict of Interest

Disclosure Statement
AOFAS mandates all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All identified conflicts must be mitigated, and the education content vetted by the AOFAS for fair balance, scientific objectivity, and appropriateness. All disclosures will be provided in this final program distributed at the meeting to all program participants.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that "off label" uses of a drug or medical device may be described in its CME activities so long as the "off label" use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used "off label" if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related Board, committee members ("planners"), faculty, and appropriate staff disclose in writing to the learners all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant's disclosure appears after his or her name as well as the commercial company or institution that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author's participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best-available evidence.

Podcast Faculty Disclosures

Jaeyoung Kim, MD
Nothing to Disclose

J. Benjamin Jackson MD, MBA 
Nothing to Disclose

Nicholas L. Strasser MD
Wright/Stryker medical: Grant/Research Support 

OnDemand Education Committee Disclosures (Planners)

Jason Ahuero MD
Nothing to Disclose

Nasef Mohamed N Abdelatif PhD, MD 
Arthrex Inc.: Paid Consultant 

Brad D. Blankenhorn MD
Nothing to Disclose 

Timothy Charlton MD 
Extremity Medical: Royalties

Cesar de Cesar Netto MD, PhD 
AAOS: Board member/Committee Member 
AOFAS: Board member/Committee Member 
Artelon: Paid Consultant, Royalties 
CurveBeam: Paid Consultant, Stock or stock options 
Foot & Ankle International: Editorial/Governing board - Publications 
Foot and Ankle Clinics: Editorial/Governing board - Publications 
International WBCT Society: Board member/Committee Member 
Medartis: Paid Consultant, Royalties 
Paragon 28: Grant/Research Support, Paid Consultant, Royalties 
Stryker: Paid Consultant 
Tayco Brace: Stock-privately held company 
Zimmer-Biomet: Paid Consultant, Royalties 

Tyler Gonzalez MD, MBA 
DJO: Paid Consultant 
Exactech: Paid Consultant 
Stryker: Paid Consultant 
Treace Medical Concepts Inc: Paid Consultant 

Adam T. Groth MD 
Nothing to Disclose

Mark Hagy MD 
Nothing to Disclose

Kurt Hofmann MD 
AOFAS: Board member/Committee Member 
Centric Medical: Paid Consultant 
Globus Medical: Paid Consultant 
Isto: Grant/Research Support

Anny Hsu MD 
Nothing to Disclose

J. Benjamin Jackson MD, MBA 
Nothing to Disclose

Jeffrey Jockel MD
Nothing to Disclose
 
Anish R. Kadakia MD 
Acumed: Royalties 
Arthrex Inc.: Paid Consultant, Royalties, Speakers' Bureau 
elsevier: Royalties - Publisher 
Johnson & Johnson: Royalties 

Kristin L. Kress MD 
Nothing to Disclose

Wonyong Lee MD 
Nothing to Disclose

Pamela Luk MD
AOFAS: Board member/Committee Member 

Jacob Matz FRCSC
Nothing to Disclose

Pradeep Moonot FRCS, MRCS, MS
Nothing to Disclose

Joseph Park MD
American Orthopaedic Foot and Ankle Society: Board member/Committee Member 
DePuy  A Johnson & Johnson Company: Grant/Research Support, Paid Consultant, Speakers' Bureau 
Integra LifeSciences: Grant/Research Support, Royalties - Publisher 
LifeNet Health: Paid Consultant 
Saunders/Mosby-Elsevier: Royalties - Publisher 

Sudheer C. Reddy MD
Nothing to Disclose

Jeremy Saller MD
Nothing to Disclose

Rachel Shakked MD
Arthrex Inc.: Speakers' Bureau 

Jeremy Smith MD
AAOS: Editorial/Governing board - Publications 
AOFAS: Board member/Committee Member 
Arthrex Inc.: Fellowship Support 
Patient Apps: Stock-privately held company 
Rogerson Orthopedic: Fellowship Support 
Springer Publishing: Royalties 

W. Bret Smith DO
Nothing to Disclose

Nicholas L. Strasser MD
Wright/Stryker medical: Grant/Research Support 

Eric W. Tan MD
Arthrex Inc.: Paid Consultant, Speakers' Bureau 
Red Point Medical: Paid Consultant, Stock-privately held company 
Stryker: Paid Consultant, Speakers' Bureau